Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -15.55M
March 31, 2026 -15.55M
December 31, 2025 -15.55M
September 30, 2025 -0.0426M
June 30, 2025 -0.0502M
March 31, 2025 -0.0509M
December 31, 2024 -0.055M
September 30, 2024 -0.0619M
June 30, 2024 -0.0549M
March 31, 2024 -0.0571M
December 31, 2023 -0.0551M
September 30, 2023 -0.0477M
June 30, 2023 -1.796M
March 31, 2023 -1.745M
December 31, 2022 -1.770M
September 30, 2022 -4.607M
June 30, 2022 -2.854M
March 31, 2022 -4.000M
December 31, 2021 -3.982M
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Biomerica, Inc. -3.421M
Lantheus Holdings, Inc. 412.80M
Zomedica Corp. -13.15M
IDEXX Laboratories, Inc. 1.368B
Neogen Corp. 83.20M